RASSF1A controls tissue stiffness and cancer stem‐like cells in lung adenocarcinoma
Lung cancer remains the leading cause of cancer‐related death due to poor treatment responses and resistance arising from tumour heterogeneity. Here, we show that adverse prognosis associated with epigenetic silencing of the tumour suppressor RASSF1A is due to increased deposition of extracellular m...
Auteurs principaux: | Pankova, D, Jiang, Y, Chatzifrangkeskou, M, Vendrell, I, Buzzelli, J, Ryan, A, Brown, C, O'Neill, E |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
EMBO Press
2019
|
Documents similaires
-
RASSF1A is required for the maintenance of nuclear actin levels
par: Chatzifrangkeskou, M, et autres
Publié: (2019) -
RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?
par: Scrace, S, et autres
Publié: (2012) -
Exploring the roles of the centrosomal RASSF proteins, RASSF1A & RASSF7, in stem cells & cancer
par: Bradley, L
Publié: (2017) -
TGF-β targets the hippo pathway scaffold RASSF1A to facilitate YAP/SMAD2 nuclear translocation
par: Pefani, E, et autres
Publié: (2016) -
ATM regulates a RASSF1A-dependent DNA damage response.
par: Hamilton, G, et autres
Publié: (2009)